glp-1-based therapy GLP-1 receptor agonists are transforming diabetes care by improving blood sugar control, supporting weight loss, and reducing cardiovascular risk when used appropriately. Evidence-based selection, correct dosing, and patient counseling are The GLP-1 revolution: What UAB

This means food stays in the stomach longer, which can lead to longer-lasting fullness and fewer intense hunger spikes

These are the conclusions of an observational study published in Nature Medicine

These data can become the basis for testing known GLP-1RAs as additional medication in the treatment of epilepsy, as well as for the development of new antiepileptic drugs of the GLP-1RA family aimed at microglial GLP-1R

Eli Lilly has since surged ahead with tirzepatide, branded as Mounjaro for diabetes and Zepbound for obesity

Thats disulfiram (Antabuse)

However, the effect is generally modest compared with prescription GLP-1 receptor agonists